Tag: Heart / Stroke-Related: High Cholesterol
ACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins
Strategy noninferior for three-year composite of death, myocardial infarction, stroke, or coronary revascularization
ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
Those receiving bempedoic acid had greater reduction in LDL cholesterol and significantly lower incidence of composite of major adverse cardiovascular events
Nonacceptance of Statin Recommendation Common, Especially for Women
Nonacceptance of statin therapy associated with longer time to achieve LDL cholesterol of less than 100 mg/dL
Lipid Profiles Altered in People With Severe Mental Illness
Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings
USPSTF: Evidence Lacking for Lipid Disorder Screening in Children
Current evidence is inadequate for assessing the balance of benefits and harms of screening in a pediatric population
Fracture Risk Up With Higher Levels of HDL-C in Healthy Seniors
Similar results seen when analyses stratified by sex; non-HDL-C levels not associated with fractures
Low HDL-C Linked to Coronary Heart Disease Risk in White Adults
High HDL-C is not protective against coronary heart disease in either White or Black adults
Remote Program Beneficial for Management of HTN, Cholesterol
Significant reductions seen in blood pressure and LDL-C at six and 12 months for patients enrolled in remote program
AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo
Lipid Ratios Linked to Benign Prostatic Hyperplasia Risk
TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C
